Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Average latency of taste evoked potentials
研究概览
简要总结
The FRONTAL-PEG study focuses on taste perception in frontotemporal lobar degeneration (FTLD). This neurodegenerative disease, characterised by progressive loss of nerve cells, is the second leading cause of dementia after Alzheimer's disease.
Patients with FTLD often experience olfactory disorders (= sense of smell) and eating disorders: increased appetite, increased food intake and excessive consumption of sugary foods and snacking. This often leads to excessive weight gain. These eating disorders are still poorly understood at present.
In this context, we hypothesise that an alteration in the gustatory pathway - i.e. the way in which the brain perceives taste - could contribute to the eating disorders frequently observed in frontotemporal dementia (FTD), particularly in the marked attraction to sweet foods. We therefore wish to objectively evaluate the taste response to a sweet solution (sucrose) in patients with FTLD, using taste evoked potentials (TEPs). Taste evoked potentials are a reliable and reproducible technique for assessing brain activity in response to taste stimulation. One of their advantages is that they are non-invasive.
This study will document, for the first time in this disease, the characteristics of cortical (brain) processing of taste information.
The FRONTAL-PEG study is an interventional, regional, single-centre study conducted at the Dijon University Hospital, in collaboration with the CMRR (Memory, Resources and Research Centre) and the CSGA (Centre for Taste and Food Sciences).
All investigations are carried out at the CSGA (building adjacent to the Dijon University Hospital), with the exception of blood tests, which are carried out at the Dijon University Hospital.
The total duration of participation in the study is one morning. No follow-up is planned at the end of the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Person who has given their free and informed consent
- •Person of legal age
- •Fasting > 2 hours before PEG measurement
- •Body Mass Index (BMI) < 30 kg/m² (according to medical record data)
- •DLFT: diagnostic criteria for established or probable DLFT
排除标准
- •Persons not affiliated with or not covered by a social security scheme
- •Persons subject to legal protection measures (guardianship, trusteeship)
- •Persons subject to judicial protection measures
- •Pregnant women, women in labour or breastfeeding women
- •MMSE score < 15 and/or MoCA score < 10
- •Known COVID-19 infection within 6 months prior to inclusion
- •Active smokers (> 4 cigarettes per day on a regular basis)
- •Subject with a pacemaker (contraindication for bioelectrical impedance analysis)
- •Subject with diabetes (type 1 or type 2)
- •Taking medication (during the study) that interferes with taste
研究组 & 干预措施
Patients with frontotemporal lobar degeneration
干预措施: Blood test (Biological)
Patients with frontotemporal lobar degeneration
干预措施: Interrogation of the subject (Other)
Patients with frontotemporal lobar degeneration
干预措施: Cognitive assessment (Other)
Patients with frontotemporal lobar degeneration
干预措施: Nutritional assessment (Other)
Patients with frontotemporal lobar degeneration
干预措施: Taste tests (Other)
Patients with frontotemporal lobar degeneration
干预措施: Sucrose taste detection test (Other)
结局指标
主要结局
Average latency of taste evoked potentials
时间窗: After a fasting period of at least two hours
次要结局
未报告次要终点
